Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Traws Pharma, Inc. Director's Dealing 2013

Nov 19, 2013

35199_dirs_2013-11-18_cc5f1a56-1231-4b35-a2e7-9fcf409cd097.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Onconova Therapeutics, Inc. (ONTX)
CIK: 0001130598
Period of Report: 2013-11-15

Reporting Person: Michael & Jane Hoffman 2013 Descendants (10% Owner)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2013-11-15 Common Stock P 5000 $11.95 Acquired 4292800 Direct
2013-11-15 Common Stock P 5000 $11.99 Acquired 4297800 Direct
2013-11-15 Common Stock P 1900 $12.21 Acquired 4299700 Direct
2013-11-15 Common Stock P 7800 $11.97 Acquired 4307500 Direct